Bartlett & Co Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bartlett & Co Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	363 +1	+0.3%	+$681	﹤0.01%	464
2026 Q1	$257K	Buy	362 +1	+0.3%	+$766	﹤0.01%	419
2025 Q4	$279K	Hold	361	–	–	﹤0.01%	413
2025 Q3	$203K	Buy	361 +14	+4%	+$7.92K	﹤0.01%	446
2025 Q2	$182K	Buy	347 +3	+0.9%	+$1.67K	﹤0.01%	458
2025 Q1	$218K	Hold	344	–	–	﹤0.01%	435
2024 Q4	$245K	Hold	344	–	–	﹤0.01%	413
2024 Q3	$362K	Hold	344	–	–	0.01%	372
2024 Q2	$362K	Sell	344 -2	-0.6%	-$1.94K	0.01%	364
2024 Q1	$333K	Buy	346 +2	+0.6%	+$1.9K	0.01%	387
2023 Q4	$303K	Hold	344	–	–	﹤0.01%	413
2023 Q3	$283K	Hold	344	–	–	0.01%	406
2023 Q2	$247K	Hold	344	–	–	﹤0.01%	426
2023 Q1	$283K	Hold	344	–	–	0.01%	347
2022 Q4	$248K	Hold	344	–	–	0.01%	354
2022 Q3	$237K	Hold	344	–	–	0.01%	351
2022 Q2	$203K	Hold	344	–	–	﹤0.01%	370
2022 Q1	$240K	Hold	344	–	–	﹤0.01%	365
2021 Q4	$217K	Hold	344	–	–	﹤0.01%	381
2021 Q3	$208K	Sell	344 -9	-3%	-$5.59K	﹤0.01%	331
2021 Q2	$197K	Hold	353	–	–	﹤0.01%	333
2021 Q1	$167K	Hold	353	–	–	﹤0.01%	344
2020 Q4	$171K	Buy	353 +9	+3%	+$4.86K	﹤0.01%	341
2020 Q3	$193K	Hold	344	–	–	﹤0.01%	313
2020 Q2	$215K	Buy	344 +135	+65%	+$76.6K	0.01%	303
2020 Q1	$102K	Hold	209	–	–	﹤0.01%	367
2019 Q4	$78.5K	Hold	209	–	–	﹤0.01%	441
2019 Q3	$58K	Buy	209 +168	+410%	+$49.7K	﹤0.01%	503
2019 Q2	$12.8K	Buy	41 +1	+3%	+$333	﹤0.01%	571
2019 Q1	$16.4K	Hold	40	–	–	﹤0.01%	536
2018 Q4	$14.9K	Hold	40	–	–	﹤0.01%	543
2018 Q3	$16.2K	Hold	40	–	–	﹤0.01%	561
2018 Q2	$13.8K	Hold	40	–	–	﹤0.01%	569
2018 Q1	$13.8K	Buy	+40	New	+$13.9K	﹤0.01%	577

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bartlett & Co Wealth Management's REGN Position: Q2 2026 in Review

Bartlett & Co Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.28% in Q2 2026, buying an estimated $681 and bringing the position to 363 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Bartlett & Co Wealth Management first reported a position in REGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $362K in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Bartlett & Co Wealth Management held 363 shares of Regeneron Pharmaceuticals worth $226K as of Q2 2026.
Bartlett & Co Wealth Management bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
Regeneron Pharmaceuticals made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #464 holding.
Bartlett & Co Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
Bartlett & Co Wealth Management's Regeneron Pharmaceuticals position peaked at $362K in Q3 2024.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.